Last reviewed · How we verify
Irritable bowel syndrome with diarrhea
Approved treatments
- Viberzi · AbbVie
Viberzi works by activating the mu-opioid receptor in the gut to slow down bowel movements and reduce diarrhea. - xifaxan · Children's Hospital Los Angeles
- Lotronex · Legacy Pharma
Lotronex works by blocking serotonin receptors in the gut to slow down bowel movements. - Xifaxan · Bausch Health
- Rifaximine · Ain Shams University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Irritable bowel syndrome with diarrhea patent landscape — cliff calendar, originator estates, attackable patents
- Irritable bowel syndrome with diarrhea treatment landscape brief
- Irritable bowel syndrome with diarrhea treatment updates RSS
Frequently asked questions about Irritable bowel syndrome with diarrhea
What drugs treat Irritable bowel syndrome with diarrhea?
Tracked treatments include Viberzi, xifaxan, Lotronex, Xifaxan, Rifaximine.
What is the treatment for Irritable bowel syndrome with diarrhea?
Standard treatment for Irritable bowel syndrome with diarrhea includes Viberzi, xifaxan, Lotronex, Xifaxan, Rifaximine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Irritable bowel syndrome with diarrhea patent cliff · Irritable bowel syndrome with diarrhea CI report
- Treatment: Viberzi · AbbVie
- Treatment: xifaxan · Children's Hospital Los Angeles
- Treatment: Lotronex · Legacy Pharma
- Treatment: Xifaxan · Bausch Health
- Treatment: Rifaximine · Ain Shams University
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing